6M
VIVO

6 Meridian’s Meridian Bioscience Inc VIVO Stock Holding History

6 Meridian’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,152
Closed -$336K – 522
2021
Q2 		$336K Sell
15,152
-212
-1% -$4.5K 0.03% 219
2021
Q1 		$403K Buy
15,364
+2,334
+18% +$55.5K 0.03% 191
2020
Q4 		$244K Buy
13,030
+326
+3% +$6.09K 0.02% 235
2020
Q3 		$216K Sell
12,704
-32,874
-72% -$639K 0.02% 233
2020
Q2 		$1.06M Sell
45,578
-74,036
-62% -$1.07M 0.11% 115
2020
Q1 		$1M Buy
119,614
+40,518
+51% +$341K 0.11% 118
2019
Q4 		$773K Buy
79,096
+7,232
+10% +$67.9K 0.07% 179
2019
Q3 		$682K Buy
71,864
+29,480
+70% +$311K 0.07% 183
2019
Q2 		$504K Buy
42,384
+1,964
+5% +$23.7K 0.05% 306
2019
Q1 		$712K Buy
+40,420
New +$672K 0.07% 141

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

6 Meridian's VIVO Position: Q3 2021 in Review

6 Meridian sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 15,152 shares — an estimated $336K sold.

6 Meridian first reported a position in VIVO in Q1 2019 and held it in 10 quarters. The position peaked at $1.06M in Q2 2020. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • 6 Meridian reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • 6 Meridian sold 15,152 Meridian Bioscience Inc shares in Q3 2021, an estimated $336K.
  • 6 Meridian first reported a position in Meridian Bioscience Inc in Q1 2019 and held it in 10 quarters.
  • 6 Meridian's Meridian Bioscience Inc position peaked at $1.06M in Q2 2020.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.